Maryland Stem Cell Research Fund
Overview
The Maryland Stem Cell Research Fund (MSCRF) is dedicated to developing and supporting innovative research into all aspects of stem-cell-based technologies, and accelerate stem cell research, commercialization and cures, to develop new medical strategies for the prevention, diagnosis, treatment and cure of human diseases, injuries and conditions through human stem cells. The MSCRF operates several different programs to address all levels of research and commercialization, by promoting state-funded stem cell research through grants to public and private entities in the state.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nanochon | Oct 2025 | Grant | Co-investor |
| Agnos Therapeutics | May 2024 | Grant | Co-investor |
| Q Therapeutics, Inc. | - | Grant | Co-investor |
| RoosterBio | May 2023 | Grant | Co-investor |
| Sentien Biotechnologies | Sep 2021 | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Maryland Stem Cell Research Fund based?
Maryland Stem Cell Research Fund is headquartered in Columbia, Maryland, United States.
When was Maryland Stem Cell Research Fund founded?
Maryland Stem Cell Research Fund was founded in 2006.
How many portfolio companies does Maryland Stem Cell Research Fund have?
Maryland Stem Cell Research Fund has 13 portfolio companies in Caplight's dataset.
What are some companies in Maryland Stem Cell Research Fund's portfolio?
Portfolio companies visible on Caplight include Nanochon, Agnos Therapeutics, Q Therapeutics, Inc., RoosterBio, Sentien Biotechnologies.
What was Maryland Stem Cell Research Fund's most recent investment shown here?
Maryland Stem Cell Research Fund's most recent investment in this portfolio sample was in Nanochon in 2025.
What sectors does Maryland Stem Cell Research Fund focus on?
Maryland Stem Cell Research Fund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Maryland Stem Cell Research Fund focus on?
Maryland Stem Cell Research Fund typically invests at the MultiStage stage.
What is Maryland Stem Cell Research Fund's AUM?
Maryland Stem Cell Research Fund's assets under management are estimated between $100.0M and $250.0M.